ASX:MP1
ASX:MP1IT

Megaport and DartPoints Partnership Could Be a Game Changer for Megaport (ASX:MP1)

Earlier this month, Megaport and DartPoints announced a partnership to bring Megaport's cloud connectivity platform to DartPoints' Greenville Data Center, marking Megaport’s first presence in South Carolina and opening access to over 975 data centers and 380-plus cloud onramps across the region. This collaboration allows regional enterprises to provision private cloud connections with reduced latency and lower bandwidth costs, positioning Greenville as a key Southeast hub for hybrid cloud...
ASX:CRD
ASX:CRDOil and Gas

ASX Penny Stocks To Watch In July 2025

As the Australian market faces a slight downturn, with ASX 200 futures indicating a dip, investors are keeping a close eye on opportunities that can weather economic uncertainties. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential value and growth prospects. By focusing on those with solid financials and clear growth potential, investors may uncover promising opportunities among smaller or newer companies.
ASX:MSB
ASX:MSBBiotechs

ASX Growth Stocks With High Insider Stakes

The Australian market has faced a mixed bag of developments recently, with the ASX experiencing fluctuations amid discussions of potential interest rate cuts and global trade uncertainties. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best, offering a degree of stability amidst broader market volatility.
ASX:IMM
ASX:IMMBiotechs

High Growth Tech Stocks To Watch In Australia July 2025

The Australian market has experienced a downward trend recently, influenced by the Reserve Bank of Australia's cautious stance on interest rate cuts and uncertainties surrounding upcoming U.S. tariffs. In this environment, identifying high-growth tech stocks requires careful consideration of their resilience to economic shifts and their potential to capitalize on emerging technological trends.
ASX:NXL
ASX:NXLSoftware

ASX Stocks That May Be Trading Below Their Estimated Value July 2025

The Australian market recently experienced a downward slide as investors reacted to Reserve Bank comments cautioning against expectations of an August rate cut, while global uncertainties such as impending US tariffs add further complexity. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities, especially when considering sectors like Real Estate and Health Care that have shown varied performance.
ASX:ALK
ASX:ALKMetals and Mining

3 Promising ASX Penny Stocks With Market Caps Under A$500M

The Australian stock market has faced a mixed bag of performances, with recent comments from the RBA and global trade tensions influencing investor sentiment. For those exploring opportunities beyond the well-known companies, penny stocks—typically smaller or newer enterprises—remain an intriguing area for potential growth. Despite their vintage name, these stocks can offer surprising value and stability when backed by solid financial foundations.
ASX:ALX
ASX:ALXInfrastructure

The Bull Case For Atlas Arteria (ASX:ALX) Could Change Following Virginia Court Ruling on Dulles Greenway – Learn Why

On 17 July 2025, Atlas Arteria reported that the Supreme Court of Virginia upheld a 2024 decision rejecting a toll rate increase for the Dulles Greenway, and that related federal litigation will now proceed. This development places continued regulatory and legal uncertainty on the Dulles Greenway asset, influencing both its revenue potential and operational stability. We'll explore how ongoing legal challenges regarding toll rates could shape Atlas Arteria's investment narrative in the near...
ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Is Up 44.1% After Strong Initial Sales of FDA-Approved Ryoncil

Earlier this year, Mesoblast reported robust initial sales for Ryoncil, its first commercial cell therapy product approved by the US FDA last December to treat complications in children following bone marrow transplants. This marks the company's transition from a lengthy development phase to generating its first significant product-based revenue stream in over two decades. We’ll explore how the launch of Ryoncil as a new revenue driver may shape Mesoblast’s broader investment story. AI is...
ASX:EDV
ASX:EDVConsumer Retailing

AI Recognition Could Be a Game Changer for Endeavour Group (ASX:EDV)

In a recent study, Endeavour Group, owner of Dan Murphy’s, was identified as a potential winner among companies leveraging artificial intelligence to enhance their business models. The report highlights four main ways to benefit from the AI boom, positioning Endeavour Group as an unexpected prospect within the technology-investment landscape. This new recognition suggests a shift in how technology integration could play a meaningful role in the future direction of Australia's traditional...